CAMBRIDGE, Mass., Aug. 25, 2022 -- Aktis Oncology, a biotechnology company discovering and developing novel classes of targeted alpha radiopharmaceuticals to treat a broad range of solid tumors, today announced...
Jeff Collins was elected to a 3-year term on the Board of Directors of NCBIO at its annual meeting, in Winston-Salem, NC
News | 05. 19. 2008
NCBIO elected four new members to the organization’s Board of Directors and re-elected six other individuals at the annual meeting in Winston-Salem, May 19th. Jeff Collins, Executive in Residence, Pappas Ventures; Norris Tolson, President and CEO of the NC Biotechnology Center; Susan Thomason, Executive Director Global Business Development, NovaQuest; and Jan Turek, President and CEO of Biolex Therapeutics will serve until 2011.
